Polycystic kidney disease

C Bergmann, LM Guay-Woodford, PC Harris… - Nature reviews Disease …, 2018 - nature.com
Cystic kidneys are common causes of end-stage renal disease, both in children and in
adults. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive …

Autosomal dominant polycystic kidney disease

E Cornec-Le Gall, A Alam, RD Perrone - The Lancet, 2019 - thelancet.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
kidney disease and one of the most common causes of end-stage kidney disease. Multiple …

Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy

FT Chebib, VE Torres - American Journal of Kidney Diseases, 2021 - Elsevier
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited
cause of kidney failure, accounting for 5%-10% of cases. Predicting which patients with …

Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model

NM Pastor-Soler, H Li, J Pham… - American Journal …, 2022 - journals.physiology.org
Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in the
polycystin 1 (PKD1) or polycystin 2 genes, presents with progressive development of kidney …

Hydration for health hypothesis: a narrative review of supporting evidence

ET Perrier, LE Armstrong, JH Bottin, WF Clark… - European journal of …, 2021 - Springer
Purpose An increasing body of evidence suggests that excreting a generous volume of
diluted urine is associated with short-and long-term beneficial health effects, especially for …

Clinical and genetic heterogeneity of primary ciliopathies

IO Focșa, M Budișteanu… - … journal of molecular …, 2021 - spandidos-publications.com
Ciliopathies comprise a group of complex disorders, with involvement of the majority of
organs and systems. In total,> 180 causal genes have been identified and, in addition to …

Drugs in clinical development to treat autosomal dominant polycystic kidney disease

T Bais, RT Gansevoort, E Meijer - Drugs, 2022 - Springer
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive
cyst formation that ultimately leads to kidney failure in most patients. Approximately 10% of …

Cell and gene therapy for kidney disease

JL Peek, MH Wilson - Nature Reviews Nephrology, 2023 - nature.com
Kidney disease is a leading cause of morbidity and mortality across the globe. Current
interventions for kidney disease include dialysis and renal transplantation, which have …

[HTML][HTML] Renal ciliopathies: sorting out therapeutic approaches for nephronophthisis

MF Stokman, S Saunier, A Benmerah - Frontiers in cell and …, 2021 - frontiersin.org
Nephronophthisis (NPH) is an autosomal recessive ciliopathy and a major cause of end-
stage renal disease in children. The main forms, juvenile and adult NPH, are characterized …

[PDF][PDF] Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial

S Cukoski, CH Lindemann, S Arjune, P Todorova… - Cell Reports …, 2023 - cell.com
Ketogenic dietary interventions (KDIs) are beneficial in animal models of autosomal-
dominant polycystic kidney disease (ADPKD). KETO-ADPKD, an exploratory, randomized …